We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Novel Label-Free Protein Assay System Certified Compatible with CCD Spectrometer Microplate Readers

By LabMedica International staff writers
Posted on 08 Aug 2012
Several instruments manufactured by one of Europe's leading producers of microplate spectrophotometers have been certified as to being completely compatible with a novel, label-free protein assay system.

SPECTROstar Nano, SPECTROstar Omega, FLUOstar Omega, POLARstar Omega, and PHERAstar FS are microplate readers equipped with CCD (charge-coupled device) spectrometers. More...
These instruments, made by the dedicated manufacturer of microplate readers BMG Labtech (Ortenberg,Germany) have been certified as being fully compatible with PharmaDiagnostics' (Zellik, Belgium) SoPRano assay system.

The SoPRano assay is based on an adaptation of surface plasmon resonance (SPR) technology known as localized surface plasmon resonance (LSPR). In this system, gold nano rods (GNR) in solution are coated with the protein of interest. When the target protein molecules attached to the surface of the GNR’s interact with a ligand, a highly reproducible and dose dependent absorbance change occurs, which manifests as a redshift in the maximum absorbance wavelength. This is measured on a standard absorbance plate reader in either 96- or 384-well format.

The SoPRano assay system does not require specialized SPR detection equipment. Instead, a standard liquid handler and UV-Vis plate reader (scanning) capable of signal measurement up to 1000 nm are all that are needed.

This technology is broadly enabling and has been adapted for a variety of applications in basic research, pharmaceutical discovery, and quality control. Current applications include real-time kinetics, antibody-antigen interactions, epitope mapping; protein-protein interaction assays, and small molecule protein-protein inhibition assays.

Dr. E. J. Dell, international marketing director at BMG Labtech, said, “Since the whole absorbance spectrum redshifts when molecules bind to the SoPRano GNR surface, a whole spectrum needs to be measured. In less than one second per well and at a resolution of one nanometer, our CCD spectrometer microplate readers can instantly capture an entire absorbance spectrum (220-1,000 nm). Other microplate readers have to ‘build’ the spectrum, this can take tens of seconds (or even minutes) and it is usually at a lower resolution. This makes BMG Labtech’s CCD spectrometer microplate readers perfect for the SoPRano label-free assay.”

“The BMG Labtech spectrometer technology and dedicated SoPRano software enhance data quality and ease of use for SoPRano users. The combination of the BMG Labtech readers and SoPRano technology now deliver label-free, high quality protein-protein interactions analysis at a cost level an order of magnitude lower than specialist SPR systems, making this valuable technique available to any life science lab”, said Julian Abery, vice president for business development at PharmaDiagnostics.

Related Links:
BMG Labtech



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.